Is Creative Medical Stock a Good Investment?
Creative Medical Investment Advice | CELZ |
- Examine Creative Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Creative Medical's leadership team and their track record. Good management can help Creative Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Creative Medical's business and its evolving consumer preferences.
- Compare Creative Medical's performance and market position to its competitors. Analyze how Creative Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Creative Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Creative Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Creative Medical Technology stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Creative Medical Technology is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Creative Medical Stock
Researching Creative Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book (P/B) ratio of 0.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. Creative Medical Tec recorded a loss per share of 3.71. The entity last dividend was issued on the 3rd of February 2020. The firm had 1:10 split on the 12th of June 2023.
To determine if Creative Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Creative Medical's research are outlined below:
| Creative Medical Tec had very high historical volatility over the last 90 days | |
| Creative Medical Tec has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 11 K. Net Loss for the year was (5.49 M) with profit before overhead, payroll, taxes, and interest of 6.6 K. | |
| Creative Medical Technology currently holds about 22.86 M in cash with (5.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.62. | |
| Creative Medical Tec has a frail financial position based on the latest SEC disclosures |
Creative Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Creative Medical Technology. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Creative Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Creative Medical's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.58 M.Basic technical analysis of Creative Stock
As of the 26th of March, Creative Medical shows the mean deviation of 6.37, and Risk Adjusted Performance of 0.04. Creative Medical Tec technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Creative Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Creative Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Creative Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Creative Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Creative Medical's Outstanding Corporate Bonds
Creative Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Creative Medical Tec uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Creative bonds can be classified according to their maturity, which is the date when Creative Medical Technology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Creative Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Creative Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.04 | |||
| Market Risk Adjusted Performance | 0.1815 | |||
| Mean Deviation | 6.37 | |||
| Semi Deviation | 8.79 | |||
| Downside Deviation | 9.31 | |||
| Coefficient Of Variation | 2733.05 | |||
| Standard Deviation | 9.14 | |||
| Variance | 83.53 | |||
| Information Ratio | 0.0358 | |||
| Jensen Alpha | 0.3291 | |||
| Total Risk Alpha | 0.351 | |||
| Sortino Ratio | 0.0351 | |||
| Treynor Ratio | 0.1715 | |||
| Maximum Drawdown | 56.11 | |||
| Value At Risk | (10.33) | |||
| Potential Upside | 18.61 | |||
| Downside Variance | 86.61 | |||
| Semi Variance | 77.31 | |||
| Expected Short fall | (6.60) | |||
| Skewness | 0.1314 | |||
| Kurtosis | 2.11 |
| Risk Adjusted Performance | 0.04 | |||
| Market Risk Adjusted Performance | 0.1815 | |||
| Mean Deviation | 6.37 | |||
| Semi Deviation | 8.79 | |||
| Downside Deviation | 9.31 | |||
| Coefficient Of Variation | 2733.05 | |||
| Standard Deviation | 9.14 | |||
| Variance | 83.53 | |||
| Information Ratio | 0.0358 | |||
| Jensen Alpha | 0.3291 | |||
| Total Risk Alpha | 0.351 | |||
| Sortino Ratio | 0.0351 | |||
| Treynor Ratio | 0.1715 | |||
| Maximum Drawdown | 56.11 | |||
| Value At Risk | (10.33) | |||
| Potential Upside | 18.61 | |||
| Downside Variance | 86.61 | |||
| Semi Variance | 77.31 | |||
| Expected Short fall | (6.60) | |||
| Skewness | 0.1314 | |||
| Kurtosis | 2.11 |
Consider Creative Medical's intraday indicators
Creative Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Creative Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Creative Medical time-series forecasting models is one of many Creative Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Creative Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Creative Stock media impact
Far too much social signal, news, headlines, and media speculation about Creative Medical that are available to investors today. That information is available publicly through Creative media outlets and privately through word of mouth or via Creative internal channels. However, regardless of the origin, that massive amount of Creative data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Creative Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Creative Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Creative Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Creative Medical alpha.
Creative Medical Corporate Executives
Elected by the shareholders, the Creative Medical's board of directors comprises two types of representatives: Creative Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creative. The board's role is to monitor Creative Medical's management team and ensure that shareholders' interests are well served. Creative Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creative Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Donald MBA | CFO VP | Profile |
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.